Unmet Needs in Schizophrenia

Dr. Henry Nasrallah, CURESZ Executive Vice President and Scientific Director, speaks with Bethany Yeiser, CURESZ President, about unmet needs in schizophrenia in 2025. Topics discussed include the need for medications for negative symptoms and cognitive deficits, treatment resistance, and comorbidities including substance use. Dr Nasrallah discusses his Cognition Self-Assessment Rating Scale (C-SARS) for cognition, and brain inflammation in schizophrenia. Find us online! Facebook:   / cureszorg   Twitter:   / cureszorg   Instagram:   / cureszfoundation   Youtube:    / @cureszfoundation7671